science pharmaceutical expo biotech jobs
Originally published online as doi:10.1189/jlb.0903446 on January 2, 2004

Published online before print January 2, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0903446v1
75/4/600    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O’Neill, H. C.
Right arrow Articles by Wilson, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O’Neill, H. C.
Right arrow Articles by Wilson, H. L.
(Journal of Leukocyte Biology. 2004;75:600-603.)
© 2004 by Society for Leukocyte Biology

Limitations with in vitro production of dendritic cells using cytokines

Helen C. O’Neill1 and Heather L. Wilson

School of Biochemistry and Molecular Biology, Faculty of Science, Australian National University, Canberra

1Correspondence: School of Biochemistry and Molecular Biology, Building #41, Linnaeus Way, Australian National University, Canberra, ACT 0200, Australia. E-mail: Helen.ONeill{at}anu.edu.au

Dendritic cells (DC) are the most effective antigen-presenting cells. Many studies now show that DC can be generated in vitro from a number of starting cell populations containing hematopoietic precursors. The protocols used involve different combinations of cytokines including granulocyte macrophage-colony stimulating factor (GM-CSF), which supports myeloid precursors, or interleukin-7, which supports lymphoid precursors. DC are commonly generated by in vitro culture of bone marrow or monocytes with GM-CSF and other cytokines. However, these cultures do not sustain DC production for long periods of time and do not allow the identification or study of intermediate stages in cell development. In vitro cytokine-dependent cultures of DC precursors do provide a reliable source of DC for stimulating immune responses. However, use of cells produced in cytokine-dependent cultures for the study of DC differentiation is limited, as DC development in vivo differs in cytokine dependency.

Key Words: hematopoiesis • differentiation • GM-CSF




This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
S. Roychowdhury, P. M. Vyas, and C. K. Svensson
Formation and Uptake of Arylhydroxylamine-Haptenated Proteins in Human Dendritic Cells
Drug Metab. Dispos., April 1, 2007; 35(4): 676 - 681.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
S. J. A. M. Santegoets, A. J. Masterson, P. C. van der Sluis, S. M. Lougheed, D. M. Fluitsma, A. J. M. van den Eertwegh, H. M. Pinedo, R. J. Scheper, and T. D. de Gruijl
A CD34+ human cell line model of myeloid dendritic cell differentiation: evidence for a CD14+CD11b+ Langerhans cell precursor
J. Leukoc. Biol., December 1, 2006; 80(6): 1337 - 1344.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Aguilar, D. Alvarez-Errico, A. C. Garcia-Montero, A. Orfao, J. Sayos, and M. Lopez-Botet
Molecular Characterization of a Novel Immune Receptor Restricted to the Monocytic Lineage
J. Immunol., December 1, 2004; 173(11): 6703 - 6711.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. D. Cook, E. L. Braine, and J. A. Hamilton
Stimulus-Dependent Requirement for Granulocyte-Macrophage Colony-Stimulating Factor in Inflammation
J. Immunol., October 1, 2004; 173(7): 4643 - 4651.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
H. C. O'Neill, H. L. Wilson, B. Quah, J. L. Abbey, G. Despars, and K. Ni
Dendritic Cell Development in Long-Term Spleen Stromal Cultures
Stem Cells, July 1, 2004; 22(4): 475 - 486.
[Abstract] [Full Text] [PDF]